Please Download Flash

Browse News by Year:
RSS  RSS

 

WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
Send To a Colleague Send To a Colleague Send To a Colleague
Send To a Colleague
Print Printable Version
Email To a Colleague Send to a Colleague
Send To a Colleague
Send To a Colleague Send To a Colleague Send To a Colleague

Shanghai, China, August 1, 2008 - August 1, 2008 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Mr. Steven M. Hutchins as Vice President of Business Development.